Einat Brill Almon, VP, Product Development at Protalix BioTherapeutics, Inc. (PLX), sold 48,370 shares at $2.75 ($133K) on 2008-05-12, disclosed to the SEC on 2008-05-14.
Scheduled sale ($133k) by VP, Product Development.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.78 | 6,943 | $19K | 14.5% |
| 2 | $2.75 | 41,427 | $114K | 85.5% |
| Total | $2.75 avg | 48,370 | $133K | 100% |
| Filing → |
| PLX | SELL | 2010-09-08 | $404K | — | Filing → |
| PLX | SELL | 2009-10-19 | $847K | — | Filing → |
| PLX | SELL | 2009-07-08 | $280K | — | Filing → |